Pushing Forward or Staying the Course?: Product Hopping, Exclusionary Conduct, and the Recent Suboxone MTD Ruling
1 PM EDT
The panel will discuss, in conversational format, the recent ruling on the motion to dismiss the multistate complaint in the Suboxone case. Panelists will provide background on the motion to dismiss, and will then address how the ruling fits within the existing state of the law with regard to both pharmaceutical product hops and conduct in the case that is alleged to have led to delayed generic entry (including REMS and FDA citizen petition issues).
FREE: Antitrust Section Members, Government, Non-profit Employees, Students, Other Non-Members $25.00
Explore Section benefits or call 1-800-285-2221 to join. Code RAT14IP25. For this and all upcoming events visit http://ambar.org/atevents.
The ABA is not seeking CLE credit for this program.
Audio Archive: Provided all releases are obtained, MP3 recordings of this program will be available to Section members on the Committee Program Audio page.